DrugDashboards
← Home
Manufacturing facility

Cipla Limited

A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.

Country
India
Registered address
L-139 to L-146, S-103 to S-105, S-107 to S-112, L-147 to L-147/1/2/3 L-147A, L-138, L-150, S-116, Verna Industrial Estate, Salcette, Goa 403722, India (IND)
Operations here
analysislabelmanufacturepack
FDA identifiers
FEI 3004081307 · DUNS 650072015

FDA inspection history

Outcomes of closed FDA inspections at this site (drug and biologic program areas).

  • VAIDrug Quality Assurance2024-06-21
  • OAIDrug Quality Assurance2022-08-26
  • OAIDrug Quality Assurance2019-09-27
  • VAIDrug Quality Assurance2019-01-28
  • VAIDrug Quality Assurance2018-09-28
  • VAIDrug Quality Assurance2017-06-16
  • VAIDrug Quality Assurance2016-08-30
  • VAIDrug Quality Assurance2015-04-17
  • VAIDrug Quality Assurance2013-05-30
  • VAIDrug Quality Assurance2011-11-08
  • VAIDrug Quality Assurance2011-02-17
  • VAIDrug Quality Assurance2009-04-17

Drugs this plant is listed as making

15 distinct drugs across 31 products name this site in their FDA label.

Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.